A Study of LY3025876 in Participants With Diabetes

NCT01870297 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: LY3025876
DRUG: Placebo
DRUG: Liraglutide

Sponsor

Eli Lilly and Company